Related references
Note: Only part of the references are listed.Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma
Hussein A. Tawbi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Review of bi-specific therapies in uveal melanoma
Marlana Orloff et al.
CANCER GENE THERAPY (2022)
Nivolumab Plus Ipilimumab for Treatment-Naive Metastatic Uveal Melanoma: An Open-Label, Multicenter, Phase II Trial by the Spanish Multidisciplinary Melanoma Group (GEM-1402)
Jose Maria Piulats et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Nivolumab and Ipilimumab in Metastatic Uveal Melanoma: Results From a Single-Arm Phase II Study
Meredith S. Pelster et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Phase II trial of pegylated arginine deiminase in combination with gemcitabine and docetaxel for the treatment of soft tissue sarcoma.
Brian Andrew Van Tine et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
NCT04552223: A phase II study of nivolumab plus BMS-986016 (relatlimab) in patients with metastatic uveal melanoma (UM) (CA224-094).
Jose Lutzky et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma
Paul Nathan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Arginine Signaling and Cancer Metabolism
Chia-Lin Chen et al.
CANCERS (2021)
Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers
Kwang-Yu Chang et al.
ONCOIMMUNOLOGY (2021)
Clinical Trials in Metastatic Uveal Melanoma: Immunotherapy
Marlana Orloff
OCULAR ONCOLOGY AND PATHOLOGY (2021)
Single-cell analysis reveals new evolutionary complexity in uveal melanoma
Michael A. Durante et al.
NATURE COMMUNICATIONS (2020)
Initial report of treatment of uveal melanoma with hepatic metastases with yttrium90 internal radiation followed by ipilimumab and nivolumab.
David R. Minor et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
A phase Ib study of endogenous SLC45A2-specific cytotoxic T cells for the treatment of patients with metastatic uveal melanoma.
Suzanne Phillips et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Molecular profiling of driver events in metastatic uveal melanoma
Joakim Karlsson et al.
NATURE COMMUNICATIONS (2020)
Comprehensive analysis of cutaneous and uveal melanoma liver metastases
Esmee P. Hoefsmit et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): protocol for a multicenter phase II open label study
Henrik Jespersen et al.
BMC CANCER (2019)
Immunological Backbone of Uveal Melanoma: Is There a Rationale for Immunotherapy?
Ernesto Rossi et al.
CANCERS (2019)
Molecular Characteristics of Uveal Melanoma: Insights from the Cancer Genome Atlas (TCGA) Project
Mathieu E. Bakhoum et al.
CANCERS (2019)
Immunobiology of Uveal Melanoma: State of the Art and Therapeutic Targets
Maria Sofia Basile et al.
FRONTIERS IN ONCOLOGY (2019)
Phase 1 Dose-Escalation Study of Pegylated Arginine Deiminase, Cisplatin, and Pemetrexed in Patients With Argininosuccinate Synthetase 1-Deficient Thoracic Cancers
Emma Beddowes et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
Ahmet Zehir et al.
NATURE MEDICINE (2017)
Parallel profiling of immune infiltrate subsets in uveal melanoma versus cutaneous melanoma unveils similarities and differences: A pilot study
Yong Qin et al.
ONCOIMMUNOLOGY (2017)
Immune checkpoint blockade for unresectable or metastatic uveal melanoma: A systematic review
Markus V. Heppt et al.
CANCER TREATMENT REVIEWS (2017)
Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma
A. Gordon Robertson et al.
CANCER CELL (2017)
Comprehensive Genetic Landscape of Uveal Melanoma by Whole-Genome Sequencing
Beryl Royer-Bertrand et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2016)
Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT) A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology
Donavan T. Cheng et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2015)
Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma
Michael A. Postow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Yang Liao et al.
BIOINFORMATICS (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma
Patrick A. Ott et al.
INVESTIGATIONAL NEW DRUGS (2013)
BRAF/NRAS Mutation Frequencies Among Primary Tumors and Metastases in Patients With Melanoma
Maria Colombino et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Share Paper
